NO993823D0 - 2-Amino-6-(2-substituert-4-fenoksy)-substituerte pyridiner - Google Patents

2-Amino-6-(2-substituert-4-fenoksy)-substituerte pyridiner

Info

Publication number
NO993823D0
NO993823D0 NO993823A NO993823A NO993823D0 NO 993823 D0 NO993823 D0 NO 993823D0 NO 993823 A NO993823 A NO 993823A NO 993823 A NO993823 A NO 993823A NO 993823 D0 NO993823 D0 NO 993823D0
Authority
NO
Norway
Prior art keywords
substituted
phenoxy
amino
pyridines
substituted pyridines
Prior art date
Application number
NO993823A
Other languages
English (en)
Other versions
NO993823L (no
NO314803B1 (no
Inventor
Iii John Adams Lowe
Jolanta Nowakowski
Robert Alfred Volkmann
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO993823L publication Critical patent/NO993823L/no
Publication of NO993823D0 publication Critical patent/NO993823D0/no
Publication of NO314803B1 publication Critical patent/NO314803B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/73Unsubstituted amino or imino radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO19993823A 1997-02-10 1999-08-09 2-Amino-6-(2-substituert-4-fenoksy)-substituerte pyridiner, anvendelse derav, farmasöytiske preparater inneholdende disse, og mellomprodukterved fremstilling derav NO314803B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3753397P 1997-02-10 1997-02-10
PCT/IB1998/000112 WO1998034919A1 (en) 1997-02-10 1998-01-29 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines

Publications (3)

Publication Number Publication Date
NO993823L NO993823L (no) 1999-08-09
NO993823D0 true NO993823D0 (no) 1999-08-09
NO314803B1 NO314803B1 (no) 2003-05-26

Family

ID=21894849

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19993823A NO314803B1 (no) 1997-02-10 1999-08-09 2-Amino-6-(2-substituert-4-fenoksy)-substituerte pyridiner, anvendelse derav, farmasöytiske preparater inneholdende disse, og mellomprodukterved fremstilling derav

Country Status (44)

Country Link
US (2) US20010007873A1 (no)
EP (1) EP0958282B1 (no)
JP (1) JP3505189B2 (no)
KR (1) KR100460399B1 (no)
CN (3) CN1523015A (no)
AP (1) AP833A (no)
AR (1) AR011117A1 (no)
AT (1) ATE271544T1 (no)
AU (1) AU744313B2 (no)
BG (1) BG103633A (no)
BR (1) BR9811093A (no)
CA (1) CA2277990C (no)
CO (1) CO4920225A1 (no)
CZ (1) CZ292135B6 (no)
DE (1) DE69825147T2 (no)
DK (1) DK0958282T3 (no)
DZ (1) DZ2414A1 (no)
EA (1) EA003834B1 (no)
ES (1) ES2224354T3 (no)
GT (1) GT199800032A (no)
HN (1) HN1998000030A (no)
HR (1) HRP980069A2 (no)
HU (1) HUP0000762A3 (no)
IL (1) IL130898A0 (no)
IS (1) IS5118A (no)
MA (1) MA27676A1 (no)
MY (1) MY120976A (no)
NO (1) NO314803B1 (no)
NZ (2) NZ518345A (no)
OA (1) OA11084A (no)
PA (1) PA8446301A1 (no)
PE (1) PE58599A1 (no)
PL (1) PL335161A1 (no)
PT (1) PT958282E (no)
SI (1) SI0958282T1 (no)
SK (1) SK101199A3 (no)
TN (1) TNSN98024A1 (no)
TR (1) TR199901917T2 (no)
TW (1) TW458969B (no)
UA (1) UA64740C2 (no)
UY (1) UY24881A1 (no)
WO (1) WO1998034919A1 (no)
YU (1) YU35699A (no)
ZA (1) ZA981017B (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010049379A1 (en) 1997-08-27 2001-12-06 Lowe John Adams 2-aminopyridines containing fused ring substituents
CN1303379A (zh) * 1998-06-03 2001-07-11 辉瑞产品公司 作为氧化氮合酶抑制剂的含稠环取代基的2-氨基吡啶
PL346842A1 (en) * 1998-08-11 2002-02-25 Pfizer Prod Inc New pharmaceutical uses for nos inhibitors
SE9803710L (sv) 1998-09-25 2000-03-26 A & Science Invest Ab Användning av vissa substanser för behandling av nervrotsskador
US7115557B2 (en) 1998-09-25 2006-10-03 Sciaticon Ab Use of certain drugs for treating nerve root injury
ES2200813T3 (es) * 1999-02-25 2004-03-16 Pfizer Products Inc. 2-aminopiridinas que contienen sustituyentes de anillo condesado.
FR2812635B1 (fr) * 2000-08-01 2002-10-11 Aventis Pharma Sa Nouveaux composes heterocycliques, preparation et utilisation comme medicaments notamment comme anti- bacteriens
GB0019006D0 (en) * 2000-08-04 2000-09-20 Astrazeneca Ab Novel compounds
US20030232739A1 (en) * 2001-08-15 2003-12-18 Pfizer Inc. Pharmaceutical combinations comprising a NOS inhibitor and an NMDA receptor antagonist
US20030045449A1 (en) * 2001-08-15 2003-03-06 Pfizer, Inc. Pharmaceutical combinations for the treatment of neurodegenerative diseases
US6803470B2 (en) 2001-10-10 2004-10-12 Pfizer Inc 2-amino-6-(2,4,5-substituted-phenyl)-pyridines
DOP2002000467A (es) * 2001-10-10 2003-04-15 Pfizer Prod Inc 2-amino-6 (fenilo sustituido en las posiciones 2,4,5)-piridinas
US7045652B2 (en) * 2002-07-03 2006-05-16 Pfizer Inc Processes for preparing substituted aryl boronic acids
US20040092741A1 (en) * 2002-11-08 2004-05-13 Pfizer Inc Substituted pyridines via boronic acid coupling
WO2005007627A1 (ja) * 2003-07-18 2005-01-27 Nihon Nohyaku Co., Ltd. フェニルピリジン誘導体、その中間体及びこれを有効成分とする除草剤
JP2008545616A (ja) * 2005-02-21 2008-12-18 プロキシマジェン エルティーディー ジスキネジーの阻害または治療
GB0607196D0 (en) * 2006-04-11 2006-05-17 Prosidion Ltd G-protein coupled receptor agonists
TW200835487A (en) * 2006-12-28 2008-09-01 Basf Ag 2-substituted pyridines I in therapy
UA105182C2 (ru) 2008-07-03 2014-04-25 Ньюрексон, Інк. Бензоксазины, бензотиазины и родственные соединения, которые имеют ингибирующую nos активность
AU2014221489B2 (en) 2013-02-28 2018-03-08 Tiumbio Co., Ltd. Tricyclic compound and use thereof
EP3066072B1 (en) * 2013-11-07 2021-11-03 The University of Kansas Biphenylamide derivative hsp90 inhibitors
US10562858B2 (en) * 2014-08-13 2020-02-18 Meiji Seika Pharma Co., Ltd. Crystalline anti-trichophyton agents and preparation process thereof
CN106265640B (zh) * 2016-08-11 2019-05-14 吉林大学 Appa在制备治疗糖尿病肾病药物中的应用
CN108069831B (zh) * 2018-01-25 2020-11-24 上海恩氟佳科技有限公司 一种合成2,3-二甲基-4-氟苯酚的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994014780A1 (en) * 1992-12-18 1994-07-07 The Wellcome Foundation Limited Pyrimidine, pyridine, pteridinone and indazole derivatives as enzyme inhibitors
AU688811B2 (en) * 1993-10-21 1998-03-19 G.D. Searle & Co. Amidino derivatives useful as nitric oxide synthase inhibitors
WO1996018616A1 (en) * 1994-12-12 1996-06-20 Merck & Co., Inc. Substituted 2-aminopyridines as inhibitors of nitric oxide synthase
EP1471055A1 (en) * 1996-03-29 2004-10-27 Pfizer Inc. 6-phenylpyridyl-2-amine derivatives

Also Published As

Publication number Publication date
BR9811093A (pt) 2000-07-18
US20030162765A1 (en) 2003-08-28
IL130898A0 (en) 2001-01-28
DE69825147D1 (de) 2004-08-26
ATE271544T1 (de) 2004-08-15
KR20000070803A (ko) 2000-11-25
DZ2414A1 (fr) 2003-01-04
SK101199A3 (en) 2000-10-09
KR100460399B1 (ko) 2004-12-08
DE69825147T2 (de) 2005-08-04
NZ518345A (en) 2005-02-25
MY120976A (en) 2005-12-30
EA003834B1 (ru) 2003-10-30
EP0958282B1 (en) 2004-07-21
MA27676A1 (fr) 2006-01-02
NO993823L (no) 1999-08-09
AR011117A1 (es) 2000-08-02
GT199800032A (es) 1998-02-11
EP0958282A1 (en) 1999-11-24
CZ276999A3 (cs) 2000-05-17
EA199900632A1 (ru) 2000-02-28
ZA981017B (en) 1999-08-10
HUP0000762A2 (hu) 2000-09-28
DK0958282T3 (da) 2004-11-29
HRP980069A2 (en) 1998-12-31
JP3505189B2 (ja) 2004-03-08
YU35699A (sh) 2002-06-19
WO1998034919A1 (en) 1998-08-13
IS5118A (is) 1999-07-29
CA2277990A1 (en) 1998-08-13
CN1246848A (zh) 2000-03-08
UA64740C2 (uk) 2004-03-15
AU5572798A (en) 1998-08-26
PL335161A1 (en) 2000-04-10
PA8446301A1 (es) 2000-05-24
TR199901917T2 (xx) 1999-12-21
AP833A (en) 2000-05-10
CZ292135B6 (cs) 2003-08-13
HN1998000030A (es) 1998-10-22
CO4920225A1 (es) 2000-05-29
SI0958282T1 (en) 2005-02-28
OA11084A (en) 2002-03-15
CN1523015A (zh) 2004-08-25
PE58599A1 (es) 1999-06-12
CN1515554A (zh) 2004-07-28
BG103633A (bg) 2000-11-30
CA2277990C (en) 2006-08-01
PT958282E (pt) 2004-11-30
AU744313B2 (en) 2002-02-21
ES2224354T3 (es) 2005-03-01
HUP0000762A3 (en) 2000-10-30
NZ336623A (en) 2000-11-24
TW458969B (en) 2001-10-11
US20010007873A1 (en) 2001-07-12
NO314803B1 (no) 2003-05-26
UY24881A1 (es) 2000-12-29
TNSN98024A1 (fr) 2005-03-15
JP2000509408A (ja) 2000-07-25

Similar Documents

Publication Publication Date Title
NO993823L (no) 2-Amino-6-(2-substituert-4-fenoksy)-substituerte pyridiner
ID23889A (id) Turunan-turunan piridina
NO994791L (no) Nikotinamid-derivater
MX209959B (es) 4-(3-heterociclil-1-benzoil)pirazoles
ATE260243T1 (de) N-aroylphenylalaninderivate
ATE235220T1 (de) Resorcinderivate
FI970468A0 (fi) Anvaendningspraoksberoende bokstavsmatning med nummertangenter
FI974269A0 (fi) Radiosaendare-mottagarestruktur med tvao frekvensomraoden
DE69813177D1 (de) Heissschmelz-tintenstraltintezusammensetzung
FI972664A0 (fi) Foerseglad saeck med avluftning
DE29710620U1 (de) Beheizbare Walze
DE59811530D1 (de) Zange
DE69734891D1 (de) Ausrichtvorrichtung
DE29723163U1 (de) Fahrwegelement
FI974544A0 (fi) Anordning i en med manoeverplats foersedd lastkran
FI970405A0 (fi) Plattformad traeprodukt med skiktstruktur
FI970017A0 (fi) Med lampeffekts maetning foersett reglerbart elektroniskt anslutningsorgan
DE29710040U1 (de) Beheizbare Walze
FI971071A0 (fi) Minneselement i samband med medicinfoerpackning
DK9800212U3 (da) Styreenhed
FI971819A0 (fi) Borste med stoed
FI970473A0 (fi) Vaextextraktblandning med antiherpasaktivitet
FI974642A0 (fi) Arbetsbord med tvaettho
FI972274A0 (fi) Foerfarande foer roekgasrening med snabba elektroner
FI974641A0 (fi) SOP-/torkanordning med loestagbart skaft